Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
$0.00
-75.0%
$0.00
$0.00
$0.00
$7K1.56N/A22,000 shs
Alliqua BioMedical, Inc. stock logo
ADYX
Alliqua BioMedical
$0.00
$0.00
$0.00
N/A1.98N/AN/A
AKSY
Aksys
$0.00
$0.00
$0.00
N/AN/AN/AN/A
Nexeon Medsystems Inc stock logo
NXNN
Nexeon Medsystems
$0.00
$0.00
$0.00
N/A6.98300 shs200 shs
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
-75.00%-75.00%-75.00%-75.00%-83.33%
Alliqua BioMedical, Inc. stock logo
ADYX
Alliqua BioMedical
0.00%0.00%0.00%0.00%0.00%
AKSY
Aksys
0.00%0.00%0.00%0.00%0.00%
Nexeon Medsystems Inc stock logo
NXNN
Nexeon Medsystems
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
Alliqua BioMedical, Inc. stock logo
ADYX
Alliqua BioMedical
N/AN/AN/AN/AN/AN/AN/AN/A
AKSY
Aksys
N/AN/AN/AN/AN/AN/AN/AN/A
Nexeon Medsystems Inc stock logo
NXNN
Nexeon Medsystems
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
0.00
N/AN/AN/A
Alliqua BioMedical, Inc. stock logo
ADYX
Alliqua BioMedical
0.00
N/AN/AN/A
AKSY
Aksys
0.00
N/AN/AN/A
Nexeon Medsystems Inc stock logo
NXNN
Nexeon Medsystems
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
$270K0.03N/AN/AN/A
Alliqua BioMedical, Inc. stock logo
ADYX
Alliqua BioMedical
N/AN/AN/AN/AN/AN/A
AKSY
Aksys
N/AN/AN/AN/AN/AN/A
Nexeon Medsystems Inc stock logo
NXNN
Nexeon Medsystems
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
-$510KN/A0.00N/AN/AN/AN/AN/A
Alliqua BioMedical, Inc. stock logo
ADYX
Alliqua BioMedical
N/AN/A0.00N/AN/AN/AN/AN/AN/A
AKSY
Aksys
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Nexeon Medsystems Inc stock logo
NXNN
Nexeon Medsystems
N/AN/A0.00N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
N/AN/AN/AN/AN/A
Alliqua BioMedical, Inc. stock logo
ADYX
Alliqua BioMedical
N/AN/AN/AN/AN/A
AKSY
Aksys
N/AN/AN/AN/AN/A
Nexeon Medsystems Inc stock logo
NXNN
Nexeon Medsystems
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
N/A
Alliqua BioMedical, Inc. stock logo
ADYX
Alliqua BioMedical
N/A
AKSY
Aksys
N/A
Nexeon Medsystems Inc stock logo
NXNN
Nexeon Medsystems
N/A

Insider Ownership

CompanyInsider Ownership
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
34.11%
Alliqua BioMedical, Inc. stock logo
ADYX
Alliqua BioMedical
17.40%
AKSY
Aksys
3.80%
Nexeon Medsystems Inc stock logo
NXNN
Nexeon Medsystems
61.19%
CompanyEmployeesShares OutstandingFree FloatOptionable
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
2070.91 millionN/ANot Optionable
Alliqua BioMedical, Inc. stock logo
ADYX
Alliqua BioMedical
6N/AN/ANot Optionable
AKSY
Aksys
87N/AN/ANot Optionable
Nexeon Medsystems Inc stock logo
NXNN
Nexeon Medsystems
60N/AN/ANot Optionable

Recent News About These Companies

Nexeon Medsystems (NXNN) Earnings Dates & Reports
Nexeon MedSystems Inc.
Nexeon MedSystems Inc (NXNN) Real-Time
Drug-eluting Stents: The Next Generation
Nexeon MedSystems Inc NXNN
Medtech in a Minute: A Major Underdog Victory, and More
From Slaying to Slayed: Avail Abruptly Shuts Down
Amkor and GlobalFoundries establish new strategic partnership
Nexeon MedSystems Inc. (NXNN)
New Suit - Trade Secrets
Advanced Biomedical Technologies stock logo

Advanced Biomedical Technologies OTCMKTS:ABMT

$0.0001 0.00 (-75.00%)
As of 07/7/2025 12:32 PM Eastern

Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.

Alliqua BioMedical stock logo

Alliqua BioMedical OTCMKTS:ADYX

Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-clinical candidate intended for the treatment of focal chronic pain. The company was founded in 2007 and is headquartered in San Francisco, California.

Aksys OTCMKTS:AKSY

Aksys Ltd. provides hemodialysis products and services for patients suffering from end-stage renal disease, known as chronic kidney failure. The company offers an automated personal hemodialysis system, known as the Aksys PHD, a Personal Hemodialysis System (PHD System), which is designed to enable patients to perform frequent hemodialysis at alternate sites, such as their own homes. The PHD System is designed to monitor, during the treatment, various vital statistics, including the patient's blood flow rate, the amount of water removed from the patient, the length of the treatment session, and other parameters. It also evaluates the performance of the artificial kidney in removing toxins from the patient's blood prior to each treatment, as well as automatically evaluates the water treatment filters and indicates whether a replacement is required and verifies that safety systems, sensors, and alarms are operating correctly. Aksys Ltd. also provides various services, including the delivery and installation of the PHD System; technical services, including maintenance and repair of the PHD System; delivery of consumables used in dialysis, such as the water purification components and dialysate concentrate; and artificial kidney, and arterial and venous blood tubing. The company markets its products and services, primarily to healthcare providers, such as hospitals, dialysis clinics, managed care organizations, and nephrology physician groups in the United States, the United Kingdom, and Japan. Aksys Ltd. was founded in 1991 and is headquartered in Lincolnshire, Illinois.

Nexeon Medsystems stock logo

Nexeon Medsystems OTCMKTS:NXNN

Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.